Skip to content

About Us:

Foundation News

aboutus

About Us: Foundation News

The Spinal Muscular Atrophy Foundation Rings Nasdaq Opening Bell

August 18, 2018

The Spinal Muscular Atrophy (SMA) Foundation, a non-profit, organization whose mission is to accelerate the development of treatments for SMA, the leading cause of genetic death in young children, visited the Nasdaq MarketSite in Times Square on August 17, 2018. In honor of the occasion, Dinakar Singh, Co-Founder and Chairman of the Board of Directors,…

Read More

Central and Peripheral Treatment of SMA meeting summary

November 20, 2017

On November 10th, the SMA Foundation held a meeting with over 100 SMA researchers, clinicians, and patient advocacy group representatives to discuss the potential impact of SMN upregulation outside of the central nervous system (CNS). The meeting focused on evidence from preclinical models and patients that indicate SMN has a role outside of the CNS…

Read More

Promotions and Staff Additions at the SMA Foundation

September 8, 2011

The SMA Foundation announced today that Karen Chen, PhD, has been named Chief Operating Officer (COO). In addition to Dr. Chen’s continued role as Chief Scientific Officer (CSO), she will also be responsible for managing the day-to-day business operations of the Foundation. Additionally, both Dione Kobayashi, PhD and Sergey Paushkin, MD, PhD have been promoted…

Read More

Increasing SMN Protein May Be Therapeutic Even After SMA Disease Onset

July 27, 2011

Congratulations to Umrao Monani, Assistant Professor at the Motor Neuron Center of Columbia University and Cathleen Lutz, Associate Director of Genetic Research Science at The Jackson Laboratory, and their colleagues for their new publication “Postsymptomatic Restoration of SMN Rescues the Disease Phenotype in a Mouse Model of Severe Spinal Muscular Atrophy” in the Journal of…

Read More

Congratulations to Dr. Lee Rubin for His Recent Publication in Nature Chemical Biology

June 27, 2011

Congratulations to SMA Foundation Investigator, Lee Rubin, Director of Translational Medicine at the Harvard Stem Cell Institute, and his team for publishing their article, “A Screen for Regulators of Survival of Motor Neuron Protein Levels” in Nature Chemical Biology on June 19, 2011. The article describes a novel image-based screen to identify compounds that increase…

Read More

Enzo Biochem Unit Launches First-to-Market Survival Motor Neuron (SMN) Protein Immunoassay System

March 15, 2011

FARMINGDALE, NY and NEW YORK, NY – March 15, 2011 – Enzo Biochem, Inc. and the Spinal Muscular Atrophy (SMA) Foundation today announced that Enzo’s wholly owned subsidiary, Enzo Life Sciences Inc., has launched a unique immunoassay (ELISA) system which can be used for the identification and detection of Survival Motor Neuron (SMN) protein. The kit…

Read More

Cynthia Joyce Elected Vice-Chair of the SMA Foundation Board of Directors

March 11, 2011

The SMA Foundation announced today that Cynthia Joyce will be stepping down as Executive Director of the Foundation at the end of this month. Effective April 2, 2011, Ms. Joyce will become a member of the Foundation’s Board of Directors and has been elected to the office of Vice-Chair. Ms. Joyce was the first employee…

Read More

NY State Dept. of Health Announces Genetic Diseases of Children Conference – March 8-9, 2011 in NYC

February 11, 2011

The New York State Department of Health Announces Genetic Diseases of Children…Advancing Research & Care Conference to be held on March 8-9, 2011 at the Sheraton New York Towers & Hotel in New York City. This is a national conference focused on creating opportunities to advance research and improve the delivery of health care for…

Read More

Congratulations to Dr. George Mentis for His Recent Publication in Neuron

February 10, 2011

Congratulations to SMA Foundation Investigator, George Mentis, Assistant Professor at the Motor Neuron Center of Columbia University, for his recent article “Early Functional Impairment of Sensory-Motor Connectivity in a Mouse Model of Spinal Muscular Atrophy” published in Neuron on February 10, 2011. The article examines the onset of motor neuron loss in a mouse model…

Read More

Dr. Seward Rutkove Receives $1MM Biomarker Prize from the Prize4Life Foundation

February 10, 2011

Congratulations to Foundation Investigator Seward Rutkove, the recipient of the $1MM Biomarker Prize from the Prize4Life Foundation! The Prize was awarded for Dr. Rutkove’s work to advance the use of electrical impedance myography (EIM) as a biomarker measure for ALS. The SMA Foundation funded a pilot study of EIM in children with SMA to determine…

Read More

Experienced leaders in business, media, and law, join the SMA Foundation’s Board of Directors

January 20, 2011

New York, NY – January 20, 2011 – The Spinal Muscular Atrophy Foundation announces the addition of Andrew Knight, Helen Meates, Stephen Mikita, Juli Oh and Simon Prisk to the SMA Foundation Board of Directors. They join a distinguished group of business and scientific leaders who oversee the SMA Foundation. Currently, there is no treatment…

Read More

SMA Foundation and RBM Collaborate on Biomarker Panels to Guide SMA Therapeutic Development

January 19, 2011

NEW YORK, NY AND AUSTIN, TX – January 19, 2011 – The Spinal Muscular Atrophy (SMA) Foundation and Rules-Based Medicine, Inc. (RBM) announced today that they have reached the first milestone in a program to develop a panel of plasma protein biomarkers for SMA using RBM’s Multi-Analyte Profiling (MAP) technology platform. In this collaboration, RBM…

Read More
Scroll To Top